Charles River Laboratories Intl
(CRL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | RVTY | AVTR | ||
| Company | Charles River Laboratories Intl | Revvity Inc | Avantor Inc | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 184.89 | 99.40 | 11.15 | ||
| High | 191.50 | 102.35 | 11.26 | ||
| Low | 182.47 | 98.69 | 10.92 | ||
| Latest | 189.21 | 101.59 | 11.26 | ||
| Change | +5.51 | +2.07 | +0.47 | ||
| % Change | +3.00% | +2.08% | +4.36% | ||
| Volume | 987,600 | 1,462,100 | 10,502,600 | ||
| 20-Day Average Volume | 729,290 | 1,705,610 | 12,878,990 | ||
| Previous Close | 183.70 | 99.52 | 10.79 | ||
| Industry | Medical Services | Medical Services | Medical Services | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 213.85 | 109.58 | 11.66 | ||
| 20-Day Raw Stochastic | 15.79% | 14.79% | 26.46% | ||
| 20-Day Relative Strength | 40.22 | 45.84 | 46.60 | ||
| Weighted Alpha | +30.38 | -7.82 | -34.89 | ||
| Today's Opinion | 56% Buy | 56% Buy | 88% Sell | ||
| Previous Opinion | 40% Buy | 56% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.11% since 01/30/26 | -6.63% since 01/30/26 | +3.11% since 01/30/26 | ||
| Low | 181.77 on 02/05/26 | 98.69 on 02/06/26 | 10.67 on 02/05/26 | ||
| High | 218.69 on 02/03/26 | 109.29 on 02/03/26 | 11.34 on 02/03/26 | ||
| 1-Month | |||||
| %Chg | -12.45% since 01/06/26 | -3.29% since 01/06/26 | -8.23% since 01/06/26 | ||
| Low | 181.77 on 02/05/26 | 98.69 on 02/06/26 | 10.67 on 02/05/26 | ||
| High | 228.88 on 01/13/26 | 118.30 on 01/22/26 | 12.90 on 01/14/26 | ||
| 3-Month | |||||
| %Chg | +10.73% since 11/06/25 | +13.48% since 11/06/25 | -0.53% since 11/06/25 | ||
| Low | 156.72 on 11/19/25 | 88.47 on 11/07/25 | 10.62 on 12/09/25 | ||
| High | 228.88 on 01/13/26 | 118.30 on 01/22/26 | 12.90 on 01/14/26 | ||
| 6-Month | |||||
| %Chg | +25.86% since 08/06/25 | +18.27% since 08/06/25 | +0.72% since 08/06/25 | ||
| Low | 144.26 on 09/25/25 | 81.36 on 09/04/25 | 10.62 on 12/09/25 | ||
| High | 228.88 on 01/13/26 | 118.30 on 01/22/26 | 15.93 on 10/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,311,971 | 11,517,866 | 7,677,237 | ||
| Shares Outstanding, K | 49,215 | 113,376 | 681,815 | ||
| Annual Sales | 4,049,990,000 | 2,755,030,000 | 6,783,600,000 | ||
| Annual Net Income | 22,200,000 | 270,390,000 | 711,500,000 | ||
| Last Quarter Sales | 1,004,850,000 | 698,950,000 | 1,623,800,000 | ||
| Last Quarter Net Income | 54,420,000 | 46,650,000 | -711,800,000 | ||
| 60-Month Beta | 1.63 | 1.07 | 0.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.43 on 11/05/25 | 1.70 on 02/02/26 | 0.22 on 10/29/25 | ||
| Latest Earnings Date | 02/18/26 | 04/27/26 | 02/11/26 | ||
| Most Recent Dividend | N/A | 0.070 on 01/16/26 | N/A | ||
| Next Ex-Dividends Date | N/A | 04/17/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 17.41 | 19.63 | 11.24 | ||